Francis W. Hunter

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs

Francis W. Hunter, Richard J. Young, Zvi Shalev et al. · Cancer Research · 2015 · 79 citations

Lipid Peroxidation, P450 Oxidoreductase, Pharmacotherapy +18

Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery

Mandana Hunter, Krista J. Spiller, Myrna A. Dominique et al. · Acta Neuropathologica Communications · 2021 · 72 citations · Full text

Neurochemical Biomarkers, Microglial Reaction, Rnls8 Mouse Model +16

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

Stephen M. F. Jamieson, Peter Tsai, Maria Kondratyev et al. · JCI Insight · 2018 · 58 citations · Full text

Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer

Francis W. Hunter, Huai‐Ling Hsu, Jiechuang Su et al. · Molecular Cancer Therapeutics · 2014 · 47 citations

Breast Oncology, Chemoprevention Strategy, Cancer Biology +16

Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: Comparison with other hypoxia-activated prodrugs

Francis W. Hunter, Jingli Wang, Rita Patel et al. · Biochemical Pharmacology · 2011 · 43 citations

Redox Signaling, Biochemistry, Medicine +8